Chenodeoxycholic Acid

This is a type of bile acid. Bile acids help your body digest fats. This specific acid helps break down fats in your intestines and is also used to help prevent gallstones.

Brand names:Chenix, Chenodiol, Ctexli, Chenodal
Medication

What people taking Chenodeoxycholic Acid report

Every report comes from a Lived member, sent anonymously.

Have you tried Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis?

NameHow it went

About Chenodeoxycholic Acid

What It's For

Chenodeoxycholic acid, also called chenodiol, is one of the bile acids the liver normally makes from cholesterol. Taken as a prescription tablet, it has two quite different uses, sold under different brand names. Ctexli is approved in the US to treat cerebrotendinous xanthomatosis (CTX) in adults. CTX is a rare inherited condition in which the body cannot properly turn cholesterol into bile acids. Cholesterol-related fats then build up in the brain, tendons and other tissues. Depending on the person, this can cause chronic diarrhea and cataracts in childhood, fatty lumps on tendons, and, often from early adulthood, problems with walking and coordination, seizures, nerve damage and declining memory and thinking. Ctexli, approved in 2025, was the first FDA-approved drug for CTX, although specialists had long regarded chenodeoxycholic acid as the treatment of choice. They recommend starting it as early as possible, but Ctexli itself is approved only for adults. Chenodal and generic chenodiol tablets carry an older approval for dissolving gallstones. Their label limits this to people whose gallstones would normally be removed with surgery but for whom an operation is risky because of age or other illness, and it states plainly that chenodiol is not an appropriate treatment for many people with gallstones. It works only on stones made mainly of cholesterol, which do not show up on X-rays. It does not dissolve calcified or pigment stones.

How It Works

Bile acids are made in the liver from cholesterol and released into the gut, where they help digest and absorb fats. Most are reabsorbed and carried back to the liver, which uses them as a signal to control how much new bile acid it produces. In CTX, changes in a gene called CYP27A1 leave the liver without an enzyme it needs to make chenodeoxycholic acid normally. Missing that feedback signal, the liver keeps pushing cholesterol into a pathway that cannot finish its work, and unusual by-products such as cholestanol and bile alcohols build up in tissues. Taking chenodeoxycholic acid replaces the missing bile acid. The liver senses it and slows the faulty pathway, so cholestanol and bile alcohol levels fall. Those blood and urine measurements are how specialists check that treatment is working. For gallstones, chenodiol reduces how much cholesterol the liver releases into bile. Bile that carries less cholesterol can gradually dissolve stones made of cholesterol, a process that takes many months.

Dosage & Administration

Chenodeoxycholic acid comes as a 250 mg tablet taken by mouth. For CTX, the usual adult dose of Ctexli is one tablet three times a day, with or without food, swallowed whole. If a dose is missed, skip it and take the next one at the usual time rather than doubling up. Treatment for CTX is generally long-term. For gallstones, the dose is based on body weight and split into two doses, morning and night. It starts low and is increased week by week, partly to limit diarrhea. If diarrhea develops, the prescriber may lower the dose for a while and then return to the previous dose. Doses well below the recommended range usually do not work and may make gallbladder surgery more likely, so they are not recommended. With either use, liver blood tests are taken before starting, and treatment is paused or stopped if they rise substantially. For CTX they are repeated at least once a year. For gallstones they are checked more often, usually monthly for the first three months and then every three months.

Side Effects

Diarrhea is the most common side effect. At gallstone doses it affects roughly a third of people, is usually mild, and is most likely when treatment starts or the dose goes up. In the main CTX trial, other common effects included headache, abdominal pain, constipation, raised blood pressure, muscle weakness and colds. Allergic reactions such as rash, hives, itching or facial swelling have been reported and should be reported to the prescriber. The most important serious risk is liver injury. Small rises in liver enzymes are common, especially at gallstone doses, and often settle without symptoms, which is why regular blood tests matter more than how a person feels. Stop the medicine and contact the prescriber promptly if you notice yellowing of the skin or eyes, dark urine, unusual bruising or bleeding, itching, or abdominal pain, nausea or tiredness that is new or not going away. People taking it for gallstones should also report promptly any steady pain in the upper abdomen with nausea. That pattern can signal a gallstone complication, which is different from the crampy pain that comes with medication-related diarrhea.

Interactions & Warnings

Cholestyramine and colestipol, cholesterol-lowering medicines known as bile acid sequestrants, bind chenodeoxycholic acid in the gut and stop it from being absorbed. Antacids containing aluminum can do the same. These combinations should be avoided. For gallstone treatment, estrogen (including birth control pills), clofibrate (an older cholesterol-lowering drug) and possibly other cholesterol-lowering drugs raise the amount of cholesterol in bile and can work against the medicine. People taking warfarin, a blood thinner, need closer checks of their clotting tests, because chenodeoxycholic acid can change how warfarin works and lead to unexpected bleeding. Existing liver disease or bile duct problems raise the risk of liver injury and should be discussed before starting. The gallstone label rules out use in people with known liver dysfunction, bile duct diseases such as sclerosing cholangitis, or gallstone complications that call for surgery. Pregnancy advice differs between the two labels. The older gallstone label says chenodiol should not be used by anyone who is or may become pregnant, based on liver, kidney and adrenal damage seen in unborn monkeys. The newer Ctexli label notes those animal findings but reports that decades of human case reports have not shown an increased risk of birth defects or miscarriage. Separately, a small study of women with CTX suggested that continuing treatment during pregnancy helps keep their condition stable. People with CTX who are pregnant or planning a pregnancy should make a plan with the specialist rather than stopping on their own. For gallstones, where treatment is an elective alternative to surgery, pregnancy should be avoided while taking chenodiol, and anyone who becomes pregnant should contact the prescriber promptly about stopping. For breastfeeding, no special precautions are usually needed, but the baby can be watched for diarrhea.

What to Expect

For CTX, the goal is to stop the abnormal build-up rather than to produce a quick change in how a person feels. Cholestanol and bile alcohol levels fall on treatment, and in the trial they rose again within four weeks when participants were switched to a placebo, which is why treatment usually continues long-term, with periodic liver tests and specialist follow-up. How much symptoms improve depends heavily on when treatment begins. In a long-term Dutch study, people who started before age 24 often saw neurologic symptoms improve or never develop them, while many who started later continued to worsen, and Parkinson-like movement problems (stiffness, slowness and tremor) did not respond. This is why early diagnosis matters so much in CTX. For gallstones, results come slowly and are uncertain. Ultrasound or X-ray imaging is repeated every six to nine months to check progress. In studies at full doses, stones dissolved completely within two years in about 3 in 10 people, and in roughly 4 to 6 in 10 of those with small stones. If there is no sign of shrinking within 9 to 12 months, success becomes unlikely, and treatment is stopped if there is no response by 18 months. Safety beyond 24 months has not been established. Even after complete dissolution, stones come back within five years in about half of people, so follow-up imaging continues. Cholesterol is also checked every six months, because total and LDL (low-density lipoprotein, the main cholesterol linked to heart disease) cholesterol can rise during treatment.

Questions to Ask Your Doctor

  1. 1.For my CTX, which blood or urine tests will show whether the treatment is working, and how often will we check them?
  2. 2.How often will I need liver blood tests, and what results would make us pause or stop treatment?
  3. 3.Could any of my other medicines, such as cholesterol-lowering drugs, antacids or warfarin, interfere with this one?
  4. 4.If I am planning a pregnancy or become pregnant, should I keep taking it, and how would my care change?
  5. 5.For gallstones, why is dissolving them a better choice for me than surgery, and what is the plan if they do not shrink?

Last reviewed • Oct 2026

Educational content, not medical advice.